Since January 2020, there have been over 775 million confirmed cases of Covid-19 and 7 million deaths globally. Vaccinations and increased virologic exposure in the population have attenuated the nature of the clinical illness and reduced the severe outcomes associated with the early pandemic stages. However, there is ongoing global transmission of SARS-CoV-2 and evolution of variant strains, with the potential to cause more serious illness. Only limited antiviral options are available to reduce symptomatic illness and disease progression. In an editorial, Drs. Amy C. Sherman and Lindsey R. Baden examine a trial of olgotrelvir for outpatient Covid-19 and discuss the potential benefits of the treatment. Read the full editorial: https://eviden.cc/3UW7FlF 𝗙𝗨𝗥𝗧𝗛𝗘𝗥 𝗥𝗘𝗔𝗗𝗜𝗡𝗚 Original Article by Rongmeng Jiang, MD, Hongzhou Lu, MD, Xiao Xu, MD, et al.: Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19 https://eviden.cc/3UVXptz #ClinicalTrials #MedicalResearch
NEJM Evidence’s Post
More Relevant Posts
-
#Hepatitis B causes about 36,000 deaths, and #hepatitis C about 86,000 deaths per year in @WHO_Europe Member States. 🌐 Join forces to eliminate Hepatitis in Europe! 💪 Together, @WHO_Europe, @EU_Health, and Member States can save lives. #Immunization/ #vaccination, and early detection/ #screening are key. Let's unite for a visionary action against #livercancer – a preventable disease. Spread the message: #TestTreatPrevent #EndHep #EuroTestWeek 🇪🇺🩺🔬 #EuroTestWeek #EndHep Europe WHO Regional Office for Europe EU Health and Food Safety EASL the home of Hepatology ESMO - European Society for Medical Oncology
To view or add a comment, sign in
-
-
Vaccines play a vital role in preventing infectious diseases, significantly reducing related morbidity and mortality. Yet, as the Federation of European Academies of Medicine and the KNAW - Koninklijke Nederlandse Akademie van Wetenschappen discussed in their joint symposium, adult vaccination programs in Europe often suffer from inadequate prioritization and funding. The symposium, a follow-up to FEAM's report "Immunisation for old adults in Europe," focused on vaccine hesitancy and its impact on adult immunisation. The discussions highlighted the critical need to overcome these challenges to ensure better public health outcomes. For more insights into the state of adult vaccination in Europe and to learn about strategies to combat vaccine hesitancy, watch the full symposium here: https://bit.ly/4b8Jdmd #EIW2024 #UnitedinProtection #EveryDoseCounts #VaccinesWork Mihai Netea Daphne Bussink - Voorend Radboudumc
FEAM-KNAW symposium on adult vaccination and vaccine hesitancy
To view or add a comment, sign in
-
Today, we join the World Health Organization (WHO) and its partners around the globe in recognizing #WorldHepatitisDay. Globally, there are over 200 million undiagnosed and untreated individuals living with hepatitis. Despite advancements in treatment, deaths from the virus are increasing: in 2022, 3,500 people a day – 1.3 million a year – died of hepatitis-related causes. The WHO has set a goal to eliminate viral hepatitis by 2030 through developing more advanced testing, expanding access to diagnostic tools, and encouraging the use of vaccinations. Quantori is proud to contribute to these efforts by supporting innovation in the pharmaceutical and life sciences industries, as well as the global health system overall. Learn more about how you can support WHO’s efforts and be part of the #TimeForAction to end hepatitis here: https://lnkd.in/eu4n5dJR
To view or add a comment, sign in
-
-
Today’s Ask the Experts question and answer is presented by ImmunizeOrg’s president and CEO, Dr. Kelly L. Moore. Established more than 25 years ago, our popular Ask the Experts feature offers answers to more than a thousand questions about vaccines and their administration. We regularly add new questions and answers to this feature, and review and revise all information to reflect current ACIP recommendations. Find today’s video here: https://lnkd.in/e5Atc4hu To find the full set of ImmunizeOrg's Ask the Experts Hepatitis B Vaccine Q&As, visit: https://lnkd.in/et9vMHzR #ImmunizeOrg #vaccinessavelives #savelivesimmunize #HepB #hepatitis
Ask the Experts: Hepatitis B Infection Diagnosed After Vaccination
https://www.youtube.com/
To view or add a comment, sign in
-
This #WorldImmunisationWeek we are promoting adult vaccination for the vaccine preventable respiratory diseases – COVID-19, influenza, pneumococcal pneumonia, pertussis, and RSV 💉 Our two key messages for Health Care Professionals this week are: 1. A healthcare professional recommendation for vaccination is the STRONGEST predictor of uptake. Ask your adult patients this week: Have you had your flu jab? 2. Discuss pneumococcal vaccination with your patients who have COPD, interstitial lung disease, or severe asthma. Don’t wait until they are 70 (or 50 for First Nations) for the free vaccine. Learn more here: https://lnkd.in/gK6rmnBX Check out some great work from a few of our favs below 👇 Australian College of Rural and Remote Medicine (ACRRM) Australian Medical Association Australian Primary Health Care Nurses Association (APNA) NACCHO Australia NAATSIHWP Pharmaceutical Society of Australia The Royal Australian College of General Practitioners (RACGP)
To view or add a comment, sign in
-
-
Radiation Oncologist|Consultant Pharmacist|Business Development | International Consultant | Medical Affairs Specialist
Hepatitis B vaccination is a key preventive measure against both hepatitis B infection and its associated risk of liver cancer. This vaccination is often recommended for individuals at higher risk of exposure, such as healthcare workers, and people born to mothers with hepatitis B. #VaccinateForHealth #CancerPreventionVaccine #HPVVaccination #HepatitisBVaccine #CancerPrevention #VaccinesWork #ProtectAgainstCancer
To view or add a comment, sign in
-
-
Another good reason to vaccinate—to keep life-saving medicines working. Vaccines are highly effective in preventing diseases that might otherwise require antibiotics or antimicrobial medicines to treat their symptoms and associated complications. Preventing infections through vaccination helps to reduce the need for antibiotics explains Elena Voronina, homemaker and mother of two children from the Russian Federation. https://bit.ly/3Ql9xlb “We do not want our children to get sick. Yet, all parents know how difficult it is to protect children from infections. As a parent, I believe in modern medicines, including effective antibiotics. But there is no specific treatment against some infections, so the best we can do is reduce the harm through preventive actions. There is a difference between an infection in a mild form and fighting a serious illness. All children should be protected from serious illnesses and their complications. Childhood vaccination provides such protection. In addition, vaccination reduces the need for the use of antibiotics, thereby preventing the development of AMR. Various side-effects of vaccination are discussed on social networks, while forgetting or turning a blind eye to the benefits of vaccination and the complications of infections. You need to think seriously before making a decision to refuse vaccination. Let’s protect our children by getting them vaccinated, and in doing so, let’s help to use antibiotics responsibly.” #WHOEuro is sharing #Stories_of_AMR throughout the year, from countries across the European Region to raise awareness about the impact of #AMR. Let’s prevent #AMR together. #AMRAwareness; #onehealth; #saveantibiotics; #handlewithcare; #WHO; #WHOEuro; #HealthForAll; #everydosecounts; #EIW2024
To view or add a comment, sign in
-
-
CEO and Board Member | General Manager | Deep experience in pharma, health, research, and life sciences
As much as we may hope it was not the case, #covid19 remains an ongoing concern. Individuals with #CLL are at greater risk of severe consequences and are less protected by vaccination. CLL Canada has prepared a detailed look at the risks of complications and the availability and effectiveness of #covid treatments in CLL patients. Check out their updated guide: https://lnkd.in/gQvq8uvR #patientsfirst #BeiGeneCAN
To view or add a comment, sign in
-
Fulbright Scholar @ Brigham & Women's Hospital, Harvard University | PhD fellow @ Center for Translational Cardiology and Pragmatic Randomized Trials, Gentofte Hospital, University of Copenhagen | DARE alumni
Excited to share our latest analysis from the NUDGE-FLU trial! 🗞 Do influenza vaccine nudges influence vaccination rates among people with diabetes to a different degree than those without diabetes? We found in this secondary analysis of the NUDGE-FLU trial (964 870 👴 👵 ≥65 years (12.8% with diabetes), electronic 🖥 nudges increased the vaccination rate 💉 in participants without diabetes but not in those with diabetes. Trials with nudges tailored specifically for DM are needed to increase flu vaccination rate in this at-risk group! Tor Biering-Sørensen, MD, MSc, MPH, PhD Niklas Dyrby Johansen JAMA Network Open https://lnkd.in/e66N8dFY
To view or add a comment, sign in
-
-
In India, 40 million people are chronically infected with hepatitis B [1]. While most individuals recover from acute illness, some with chronic hepatitis B may develop progressive liver diseases, including cancer, which can be life-threatening. While hepatitis B can be prevented with vaccinations, most Indians aren’t aware of the it and may not even know if they are infected. This is why, both awareness around the disease and timely diagnosis is crucial. Take charge of your health, diagnose and get yourself checked today. Discover how diagnostic screening can revolutionise healthcare at: https://lnkd.in/dWy-ZWEC #Roche | #ValueOfDiagnostics | #Hepatitis Source: 1. https://lnkd.in/d_gigQ69
To view or add a comment, sign in
-